About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5558945
Allelic
Composition
Tg(Camk2a-tTA)1Mmay/0
Fgf14Tg(tetO-MAPT*P301L)4510Kha/Fgf14+
Genetic
Background
involves: 129S6/SvEvTac * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fgf14Tg(tetO-MAPT*P301L)4510Kha mutation (2 available); any Fgf14 mutation (40 available)
Tg(Camk2a-tTA)1Mmay mutation (8 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• progressive decrease in percent of time spent freezing in response to unconditioned stimulus beginning at 2 months of age
• progressive decrease in percent of time spent freezing in response to conditioned stimulus beginning at 6 months of age
• amount of time spent in open arms of elevated plus maze is increased relative to nontransgenic mice at 6 and 10 months of age, but not 2 months
• higher ratio of time spent in open not closed arms relative to nontransgenic mice at 10 months of age, but not 2 or 6 months
• exploration of light chamber is increased relative to nontransgenic mice at 6 months of age, but not 2 or 10 months
• higher ratio of time spent in light not dark relative to nontransgenic miceat 10 months of age, but not 2 or 6 months
• decreased tendency to explore the center of the open field relative to nontransgenic mice
• mice exhibit progressive hyperactivity in open field analysis and elevated plus maze
• total distance travelled in open field assay is increased relative to nontransgenic mice at 6 and 10 months of age, but not 2 months
• average speed is increased relative to nontransgenic mice at 6 and 10 months of age, but not 2 months
• total time spent mobile is increased relative to nontransgenic mice at 6 and 10 months of age, but not 2 months

nervous system
• neurofibrilliary tangles are observed by immunostaining in the CA1 region of the hippocampus beginning at 6 months of age and progressing to an extensive pathology by 11 months of age
• neurofibrilliary tangles are observed by immunostaining in the amygdala beginning at 2 months of age and progressing to an extensive pathology by 10 months of age
• tau burden increases with age in the amygdala and CA1 region of the hippocampus

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
frontotemporal dementia DOID:9255 OMIM:600274
J:207366


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/09/2024
MGI 6.23
The Jackson Laboratory